GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner. Then, the use of tamoxifen, a selective estrogen receptor modulator (SERM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimento, Adele, Sirianni, Rosa, Casaburi, Ivan, Zolea, Fabiana, Rizza, Pietro, Avena, Paola, Malivindi, Rocco, De Luca, Arianna, Campana, Carmela, Martire, Emilia, Domanico, Francesco, Fallo, Francesco, Carpinelli, Giulia, Cerquetti, Lidia, Amendola, Donatella, Stigliano, Antonio, Pezzi, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://www.ncbi.nlm.nih.gov/pubmed/26131713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://www.ncbi.nlm.nih.gov/pubmed/26131713

Ejemplares similares